319 related articles for article (PubMed ID: 11823091)
1. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
[TBL] [Abstract][Full Text] [Related]
2. High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias.
Knudson JD; Cannon BC; Kim JJ; Moffett BS
Pediatr Cardiol; 2011 Oct; 32(7):896-903. PubMed ID: 21553267
[TBL] [Abstract][Full Text] [Related]
3. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy.
Fenrich AL; Perry JC; Friedman RA
J Am Coll Cardiol; 1995 Apr; 25(5):1195-8. PubMed ID: 7897134
[TBL] [Abstract][Full Text] [Related]
4. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
Ferlini M; Colli AM; Bonanomi C; Salvini L; Galli MA; Salice P; Ravaglia R; Centola M; Danzi GB
J Cardiovasc Med (Hagerstown); 2009 May; 10(5):372-5. PubMed ID: 19300276
[TBL] [Abstract][Full Text] [Related]
5. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia.
Hamer AW; Strathmore N; Vohra JK; Hunt VD
Pacing Clin Electrophysiol; 1993 Jul; 16(7 Pt 1):1394-400. PubMed ID: 7689205
[TBL] [Abstract][Full Text] [Related]
6. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
7. The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
Ergül Y; Özyılmaz İ; Saygı M; Tola HT; Akdeniz C; Tuzcu V
Turk Kardiyol Dern Ars; 2015 Oct; 43(7):607-12. PubMed ID: 26536985
[TBL] [Abstract][Full Text] [Related]
8. Use of flecainide in combination antiarrhythmic therapy in patients with arrhythmogenic right ventricular cardiomyopathy.
Ermakov S; Gerstenfeld EP; Svetlichnaya Y; Scheinman MM
Heart Rhythm; 2017 Apr; 14(4):564-569. PubMed ID: 27939893
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
Alboni P; Tomasi C; Menozzi C; Bottoni N; Paparella N; Fucà G; Brignole M; Cappato R
J Am Coll Cardiol; 2001 Feb; 37(2):548-53. PubMed ID: 11216977
[TBL] [Abstract][Full Text] [Related]
10. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
[TBL] [Abstract][Full Text] [Related]
12. Sotalol in the treatment of fetal dysrhythmias.
Oudijk MA; Michon MM; Kleinman CS; Kapusta L; Stoutenbeek P; Visser GH; Meijboom EJ
Circulation; 2000 Jun; 101(23):2721-6. PubMed ID: 10851210
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
Hellestrand KJ
Am J Cardiol; 1996 Jan; 77(3):83A-88A. PubMed ID: 8607396
[TBL] [Abstract][Full Text] [Related]
14. Supraventricular tachycardias in the first year of life: what is the best pharmacological treatment? 24 years of experience in a single centre.
Capponi G; Belli G; Giovannini M; Remaschi G; Brambilla A; Vannuccini F; Favilli S; Porcedda G; De Simone L
BMC Cardiovasc Disord; 2021 Mar; 21(1):137. PubMed ID: 33722203
[TBL] [Abstract][Full Text] [Related]
15. A comparison of oral flecainide and amiodarone for the treatment of recurrent supraventricular tachycardia in children.
Hill AC; Silka MJ; Bar-Cohen Y
Pacing Clin Electrophysiol; 2019 Jun; 42(6):670-677. PubMed ID: 30875081
[TBL] [Abstract][Full Text] [Related]
16. Nadolol for Treatment of Supraventricular Tachycardia in Infants and Young Children.
von Alvensleben JC; LaPage MJ; Caruthers R; Bradley DJ
Pediatr Cardiol; 2017 Mar; 38(3):525-530. PubMed ID: 27995288
[TBL] [Abstract][Full Text] [Related]
17. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
O'Leary ET; Alexander ME; Bezzerides VJ; Drogosz M; Economy KE; Friedman KG; Pickard SS; Tworetzky W; Mah DY
J Cardiovasc Electrophysiol; 2020 May; 31(5):1105-1113. PubMed ID: 32100356
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic management of supraventricular tachycardias in children. Part 1: Wolff-Parkinson-White and atrioventricular nodal reentry.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Oct; 31(10):1227-43. PubMed ID: 9337449
[TBL] [Abstract][Full Text] [Related]
19. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis.
Refaat M; El Dick J; Sabra M; Bitar F; Tayeh C; Abutaqa M; Arabi M
J Neonatal Perinatal Med; 2020; 13(2):267-273. PubMed ID: 31707376
[TBL] [Abstract][Full Text] [Related]
20. Catheter ablation of drug resistant supraventricular tachycardia in neonates and infants.
Akdeniz C; Ergul Y; Kiplapinar N; Tuzcu V
Cardiol J; 2013; 20(3):241-6. PubMed ID: 23788297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
